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1. Introduction 
Diabetes mellitus (DM) is one of the systemic diseases affecting a considerable number of 
patients (Bensch et al., 2003). Numerous experimental and clinical studies on the 
complications of diabetes mellitus have demonstrated extensive alterations in bone and 
mineral metabolism, linear growth, and body composition (Giglio and Lama, 2001).  DM is a 
metabolic disorder characterized by disturbed glucose metabolism, manifesting primarily as 
chronic hyperglycemia.   
Bone metabolism is impaired in Type 1 Diabetes Mellitus (T1DM), either through the direct 
effect of insulin deficiency or hyperglycaemia or via the more long-term effects of vascular 
disease.  Previous data suggested that osteoblast function can be corrected by restoration of 
glycaemic control, indicating that hyperglycaemia produces direct impairment of bone 
metabolism (Shyng et al., 2001). 
Growth is a highly complex mechanism resulting not only in a major change in size, but also 
in minor changes in shape.  The changes in shape of the craniofacial skeleton are of 
particular interest because pathological growth of certain anatomical regions may lead to 
functional and esthetic problems.  In the craniofacial skeleton, it has been well known that 
growth involves a mosaic of growth sites that grow at different rates and mature at different 
times (Vandeberg et al., 2004a; VandeBerg et al., 2004b), its growth and by analogy, the 
response to growth disruption is much more complex than that of the appendicular skeleton 
(Vandeberg et al., 2004a).  Different parts of the craniofacial complex might be expected to 
respond differently to the same hormonal or biomechanical stimulus (VandeBerg et al., 
2004b).  T1DM has been shown to affect the general growth of patients due to insulin 
deficiency and consequently leads to delayed skeletal maturation (Schwartz, 2003).  
2. Types of bone formation in craniofacial complex 
Bone forms in two ways, resulting in two types of mature bone – intramembranous and 
cartilage. Cartilage bone forms in a replacement process within the cartilage models of the 
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embryo and infant. Intramembranous bone forms through the activation of the osteoblast 
cell or specialized bone forming cells in one of the layers of fetal connective tissue. The 
bones of the cranial vault, the face, and the clavicle are intramembranous in origin. All other 
bones of the body form from cartilage. Intramembranous bone include the mandible, the 
maxilla, the premaxilla, the frontal bone, the palatine bone, the squamous part of temporal 
bone, the zygomatic bone, the medial plate of the pterygoid process, the vomer, the 
tympanic part of the temporal bone, the nasal bone, the lacrimal bone, and the parietal bone. 
The original pattern of intramembranous bone changes with progressive maturative growth 
when these bones begin to adapt to environmental influences. This accounts for deformities 
due to malfunction, disease and other environmental factors (Salzmann, 1979). 
3. Causes of growth problems 
Growth disturbances can be associated with specific anatomic or functional defects. They 
may be of endocrine or non endocrine origin and may result from genetic, nutritional or 
environmental factors. Disturbances in somatic growth show themselves in retardation or 
acceleration of the skeletal system, including the facial and cranial bones. Causes for growth 
problems usually fall into the following categories (Kumar, 2009): 
 Familial short stature 
Familial short stature is a tendency to follow the family's inherited short stature 
(shortness).  
 Constitutional growth delay with delayed adolescence or delayed maturation 
A child who tends to be shorter than average and who enters puberty later than 
average, but is growing at a normal rate. Most of these children tend to eventually grow 
to approximately the same height as their parents.  
 Illnesses that affect the whole body (Also called systemic diseases) 
Constant malnutrition, digestive tract diseases, kidney disease, heart disease, lung 
disease, hepatic disease, diabetes, and severe stress can cause growth problems.  
 Endocrine (hormone) diseases 
Adequate production of the thyroid hormone is necessary for normal bone growth. 
Cushing's syndrome can be caused by a myriad of abnormalities that are the result of 
hypersecretion of corticosteroids by the adrenal gland. Growth hormone deficiency 
involves a problem with the pituitary gland (small gland at the base of the brain) that 
secretes several hormones, including growth hormone.  
 Congenital (present at birth) problems in the tissues where growth occurs 
A condition called intrauterine growth restriction (IUGR), slow growth within the 
uterus occurs during a pregnancy. The baby is born smaller in weight and length than 
normal, in proportion to his/her short stature. 
4. Outline of studying the effect of diabetes mellitus on craniofacial growth 
Approximately 60% of adult bone mass including craniofacial bone is gained during the 
peak of the growth period which coincides with the onset of T1DM condition affecting the 
bone formation process (Eastell and Lambert, 2002). It is worth mentioning here that 
although T1DM condition exact etiological factors are totally unknown however; 
understanding the course of T1DM condition and its impact on craniofacial development 
may lead to improving the oral health for a large sector of the population worldwide. 
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Numerous experimental and clinical studies on the complications of DM have demonstrated 
extensive alterations in bone and mineral metabolism, linear growth, and body composition. 
Investigators in the fields of bone biology including orthodontics have long been interested 
in the general causes that affect the normal growth of the craniofacial region. T1DM has 
been shown to affect the general growth of patients with earlier onset of the disease, 
especially onset before or around the circumpubertal growth spurts (Chew, 1991).  
In general, growth of the craniofacial complex is controlled by genetic and environmental 
factors (Giglio and Lama, 2001; Yonemitsu et al., 2007).  Regulatory mechanisms responsible 
for normal morphogenesis of the face and head involve hormones, nutrients, mechanical 
forces, and various local growth factors.  The poor growth and alterations in bone 
metabolism have been associated with T1DM in both humans and experimental animals 
(Giglio and Lama, 2001).  It is of prime importance investigating the changes in craniofacial 
bone structure and dynamic bone formation in DM condition to explore the impact of the 
diabetic condition on various mandibular growth elements and bone quality. 
The following parts of this chapter are going to focus on these points: 
 Investigating the effects of juvenile diabetes on general craniofacial growth and skeletal 
maturation. 
 Analyzing the pattern of association between craniofacial morphology and skeletal 
maturation.  
 Determination of the changes in bone morphology in diabetic rat mandible using micro-
C.T. 
 Determination of the mineral apposition rate and the bone formation rate in diabetic rat 
mandible using histomorphometric analysis. 
5. Animal and experimental diabetic model 
The animal studies using diabetic model presents various advantages when compared to 
studies carried out on human diabetic cases.  Human studies can be limited by small sample 
sizes, cross-sectional designs, uncontrolled variables, and often retrospective nature, animal 
models have been used to yield more rigorous analyses (Singleton et al., 2006). 
5.1 Diabetic model 
Experimental diabetic models include the streptozotocin-induced diabetic rat and the 
spontaneously diabetic BioBreeding rat. The occurrence of different abnormalities indicating 
altered bone formation after inducing DM with streptozotocin (STZ) is well documented 
(Giglio and Lama, 2001; Hough et al., 1981; Tein et al., 1998).  Streptozotocin-induced 
diabetes mellitus (STZ-DM), caused by the destruction of pancreatic β-cells and is similar to 
T1DM in human, is characterized by mild to moderate hyperglycemia, glucosuria, 
polyphagia, hypoinsulinemia, hyperlipidemia, and weight loss.  STZ-DM also exhibits many 
of the complications observed in human DM including enhanced susceptibility to infection 
and cardiovascular disease, retinopathy, alterations in angiogenesis, delayed wound 
healing, diminished growth factor expression, and reduced bone formation (Lu et al., 2003). 
5.2 Importance of testing the uncontrolled diabetic condition 
In the usual clinical situation, although T1DM patient is treated with insulin, patient may 
still suffer from an overall poor diabetic metabolic state with an uncontrollable blood 
glucose level and a high and sometimes changing insulin requirement (Follak et al., 2004). 
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5.3 Inducing diabetic condition 
All the experimental protocols followed had been approved by the Institutional Animal 
Care and Use Committee of Tokyo Medical and Dental University, and the experiments 
were carried out under the control of the University’s Guidelines for Animal 
Experimentation. In our investigation we explored the various effects of DM using the 
streptozotocin DM model.  Twelve 3-week old male Wistar rats were used for this study.  
They were randomly divided into two groups, the control group and the diabetes group 
(DM group), each group consists of 6 rats.  The rats in the control group were injected intra-
peritoneal with a single dose of 0.1M sodium citrate buffer (pH 4.5), while the rats in the DM 
group were injected intra-peritoneal with a single dose of citrate buffer containing 60mg/kg 
body weight of streptozotocin (Sigma Chemical Co., St. Louis, MO, USA).(Alkan et al., 2002; 
McCracken et al., 2006; Shyng et al., 2001; Tein et al., 1998)  All animals were fed on standard 
Rodent diet (Rodent Diet CE-2; Japan Clea Inc., Shizuoka, Japan) with free access to water.  
Body weights, the presence of glucose in urine and blood glucose levels were recorded on 
day 0, 2, 7, 14, 21 and 28 after STZ injection. 
Diabetes condition was determined by the presence of glucose in urine and blood.  The 
urine of the rats was tested using reagent strips (Uriace Ga; TERUMO).  (Abdus Salam et al., 
2004; Matin et al., 2002)  Blood samples of the rats were obtained via vein puncture of a tail 
vein, and blood glucose levels were determined using a glucometer (Ascensia Brio. Bayer 
Medical).  Positive urine test and a blood glucose level greater than 200 mg/dl was 
considered DM.(Giglio and Lama, 2001).    
Fig. 1. shows the weights of the rats (mean±SD) in both groups.  DM group showed a 
significant decrease in weight.  After STZ injection by 48 hours the urine test showed that 
the entire DM group had a high glucose level and this was confirmed by the high blood 
glucose measurements as shown in Fig. 2. A Student’s t-test was used to compare the mean 
of weights and blood glucose levels in both groups. 
 
 
 
 
 
 
 
Fig. 1. Comparison between the changes of the rat’s weight in the control and DM group. 
The weights of the DM group are significantly decreased as compared to the weights of the 
control group (*:p<0.05). 
0
100
200
300
0 day 2 day 7 day 14 day 21 day 28 day
Experimental duration after STZ injection
W
ei
gh
t  
(g
)
Control
DM
*
*
*
(a)
W
ei
gh
t  
(g
)
W
ei
gh
t  
(g
)
 
www.intechopen.com
 The Effect of Type 1 Diabetes Mellitus on the Craniofacial Complex 
 
441 
 
Fig. 2. Line graph represents the blood glucose levels for the control and DM group. The 
blood glucose level in DM group increased significantly 48h post-STZ injection and during 
the entire experimental period. Values are mean±SD. Significant differences between the 
two groups are marked with asterisks (p< 0.05). 
6. Analytic studies conducted to test the effect of diabetic condition on 
craniofacial growth 
6.1 Cephalometric analysis 
Cephalometric measurements are still one of the most widely spread diagnostic aids crucial 
for the diagnosis of various abnormalities in the craniofacial complex (Chidiac et al., 2002).   
The protocol for examining the cephalometric measurements in DM rats involves the 
following steps:  
 Prior to each radiographic session, the rats are anaesthetized with diethyl ether and 
intraperitoneal injection of 8% chloral hydrate using 0.5ml/100g of body weight.   
 Each animal is then placed in this specially-designed apparatus (Fig. 3) to maintain 
standardized head posture and contact with the film (SGP-3, Mitsutoy, Tokyo, Japan) 
where the head of each rat is fixed firmly with a pair of ear rods oriented vertically to 
the sagittal plane and the incisors are fixed into a plastic ring.  
 The settings of lateral and dorsoventral cephalometric radiographs are 50/55kVp, 
15/10mA, and 20/60-sec impulses respectively (Singleton et al., 2006; Vandeberg et al., 
2004a; VandeBerg et al., 2004b). 
 A 10 mm steel calibration rod is incorporated into the clear acrylic table on which the 
animals are positioned for the radiographs.   
 All the radiographs are developed and scanned at high resolution by the same operator 
(Singleton et al., 2006). 
The cephalometric landmarks (Table 1; Fig. 4) were derived from previous studies on 
rodents (Engstrom et al., 1988; Kiliaridis and Thilander, 1985; Singleton et al., 2006; 
Vandeberg et al., 2004a; VandeBerg et al., 2004b).  Selected linear measurements were then 
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obtained (Table 2).  To ensure reliability and replicability of each measurement, each 
distance was digitized twice and the two values were averaged.  
 
 
Fig. 3. Apparatus for roentgenographic cephalometry 
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Fig. 4. Location of cephalometric points on radiographs: (A) Sagittal  and (B) transverse.  
www.intechopen.com
 The Effect of Type 1 Diabetes Mellitus on the Craniofacial Complex 
 
443 
 
 
 
 
 
 
 
 
 
 
On the sagittal radiograph
N: The most anterior point on the nasal bone
E: The intersection of the frontal bone and floor of anterior cranial fossa
Po: The most posterior and superior point on the skull
Ba: The most posterior and inferior point on the occipital condyle
Co: The most posterior and superior point on the mandibular condyle
Go: The most posterior point on the mandibular ramus
Mn: The most concave portion of the concavity on the inferior border of the mandibular corpus
Gn: The most inferior point on the ramus that lies on a perpendicular bisector of the line Go-Mn
Il: The most anterior and superior point on the alveolar bone of the mandibular incisor
So: The intersection of the most anterior tympanic bulla and the superior border of the sphenoid bone
CB1: The most anterior point on the occipital bone at the spheno-occipital synchondrosis
CB1′: The most posterior point on the sphenoid bone at the spheno-occipital synchondrosis
CB2: The most anterior point on the sphenoid bone at the spheno-basispheno synchondrosis
CB2′: The most posterior point on the basisphenoid bone at the spheno-basispheno-synchondrosis
Ml: The junction of the alveolar bone and the mesial surface of the first mandibular molar
Mu1: The junction of the alveolar bone and the mesial surface of the first maxillary molar
Mu2: The junction of the alveolar bone and the distal surface of the third maxillary molar
Iu: The most anterior-inferior point on the maxilla posterior to the maxillary incisors
On the transverse radiograph
Z1 & Z2: The points on the lateral portion of the zygomatic arch that produce the widest width
Go1 & Go2: The points on the angle of the mandible that produce the widest width
P1 & P2: The most anterior and medial points within the temporal fossae that produce the most narrow 
                palatal width
C1 & C2: The points on the cranium that produce the widest cranial width
 
 
 
 
 
 
 
 
 
 
 
Table 1. Definition of radiographic points 
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Neurocranium
Po-N: total skull length 
Po-E: cranial vault length 
Ba-E: total cranial base length 
So-E: anterior cranial base length 
Ba-CB1: occipital bone length 
CB1′-CB2: sphenoid bone length
Ba-So: posterior cranial base length 
Po-Ba: posterior neurocranium height 
Viscerocranium
E-N: nasal length 
Mu2-Iu: palate length 
CB2-Iu: midface length 
E-Mu1: viscerocranial height 
Mandible
Go-Mn: posterior corpus length 
Ml-Il: anterior corpus length 
Co-Il: total mandibular length
Co-Gn: ramus height 
Transverse X-ray
Go1-Go2: Bigonial width
C1-C2: Maximum cranial width
P1-P2: Palatal width
Z1-Z2: Bizygomatic width
 
Table 2. Measurements of craniofacial skeleton 
In our studies, evaluation of the craniofacial growth of diabetic rats at the age of 7 weeks 
was done using lateral and dorsoventral cephalometric radiographs. All of the data in each 
experiment were confirmed the normal distribution, so a Student’s t-test was used to 
compare the mean of each data recorded in the control group and in the DM group. All 
statistical analyses were performed at a 5% significance level using statistic software (v. 10; 
SPSS, Chicago, IL, USA). 
6.1.1 Changes in the total skull 
The size of total skull, denoted by Po-N, was significantly smaller in the DM group than in 
the control group. 
6.1.2 Changes in the neurocranium 
Cranial vault length (Po-E), total cranial base length (Ba-E), anterior cranial base length (So-
E), Occipital bone length (Ba-CB1), and posterior cranial base length (Ba-So) showed 
statistically significant decrease in DM group (Table 3, Figs. 5, 6), while other dimensions 
exhibited no significant differences. 
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Po-N total skull length  
Po-E cranial vault length 
Ba-E total cranial base length 
So-E anterior cranial base length   
Ba-CB1 occipital bone length 
Ba-So posterior cranial base length 
Table 3. Significant changes in the total skull and neurocranium 
 
 
Fig. 5. Neurocranium 
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Fig. 6. Changes in the neurocranial measurements of the control and DM group. All the 
significant measurements are shown in this figure. Values are mean±S.D. Significant 
differences between the two groups are marked with asterisks (p<0.05). 
6.1.3 Changes in the viscerocranium 
All measurements of the viscerocranium, including the nasal length (E-N), palatal length 
(Mu2-Iu), midface length (CB2-Iu), and viscerocranial height (E-Mu1) showed a statistically 
significant decrease in DM group (Table 4, Figs. 7,8) 
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E-N Nasal length 
Mu2-Iu  Palate length 
Cb2-Iu midface length  
E-Mu1 Posterior viscerocranial height  
Table 4. Significant changes in the viscerocranium 
 
 
Fig. 7. Viscerocranium 
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Fig. 8. Changes in the viscerocranial measurements of the control and DM group. All the 
viscerocranial measurements are significant. Values are mean±S.D.  Significant differences 
between the two groups are marked with asterisks (p<0.05). 
6.1.4 Changes in the mandible 
In the DM group, the posterior corpus length (Go-Mn), total mandibular length (Co-Il) and 
the ramus height (Co-Gn) were significantly shorter than in the control group (Table 5, Figs. 
9, 10), whereas no remarkable differences were found in the remaining dimensions.  
www.intechopen.com
 The Effect of Type 1 Diabetes Mellitus on the Craniofacial Complex 
 
447 
Go-Mn Posterior corpus  length 
Co-Il  Total mandibular  length 
Co-Gn Ramus height  
Table 5. Significant changes in the mandible 
 
 
Fig. 9. Mandible 
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Fig. 10. Changes in the mandible measurements of the control and DM group. Values are 
mean ± S.D. Significant differences between the two groups are marked with asterisks  
(p<0.05). 
6.1.5 Changes in the transverse X-ray 
 In transverse X-ray only the maximum cranial width (C1-C2) and the bizygomatic width 
(Z1-Z2) were statistically decreased in DM group (Table 6, Figs. 11, 12).   
All other linear measurements showed no significant differences between both groups 
 
C1-C2 Maximum cranial width 
Z1-Z2  Bizygomatic width 
Table 6. Significant changes in the transverse X-ray 
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Fig. 11. Transverse X-ray measurements 
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Fig. 12. Changes in the transverse X-ray measurements of the control and DM group. Two 
measurements in the transverse X-ray were significant. Values are mean±S.D. Significant 
differences between the two groups are marked with asterisks (p<0.05).  
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Mean SD Mean SD
41.67 0.59* 55.61 9.48
26.86 0.6* 37.12 6.35
27.74 0.64* 38.87 7.19
17.91 0.31* 24.41 3.72
8.23 1.08* 12.3 2.34
4.78 0.74 5.93 1.18
8.44 0.7* 13.61 4.23
10.03 0.83 13.14 2.81
13.07 1.56* 19.57 3.48
19.34 0.95* 25.01 4.5
20.16 1.29* 29 5.07
8.93 0.69* 16.43 5.36
10.27 1.04* 16 2.39
5.4 0.88 6.97 1.54
22.95 0.34* 31.13 5.51
12.22 1.2* 17.9 4.04
18.42 0.42 19.77 1.32
15.43 0.67* 17.03 1.16
8.5 0.41 9.19 0.52
21.9 0.33* 24 1.4
Linear measurements
DM
Neurocranium
Po-N
Po-E
Ba-E
So-E
Ba-CB1
CB1′-CB2
Ba-So
M1-I1
Po-Ba
Viscerocranium
Co-I1
E-N
Mu2-Iu
CB2-Iu
E-Mu1
C
P1-P2
Z1-Z2
Co-Gn
Transverse X-ray
Go1-Go2
C1-C2
Mandible
Go-Mn
 
 
*p<0.05 as compared to control values 
Table 7. Comparision of skeletal cephalometric measurements for Type 1 Diabetes mellitus 
(DM) and controls (C) 
6.2 Histomorphometric analysis 
6.2.1 Fluorescent dyes used for double labeling in histomorphometric analysis 
Fluorochromes are calcium binding substances that are preferentially taken up at the site of 
active mineralization of bone known as the calcification front, thus labeling sites of new 
bone formation. They are detected using fluorescent microscopy on undecalcified sections.  
Labeling bones with fluorochrome markers provides a means to study the dynamics of bone 
formation.  The rate and extent of bone deposition and resorption can be determined using 
double and triple fluorochrome labeling sequences. The sequential use of fluorochromes of 
clearly contrasting colors permits a more detailed record of events relating to calcification. 
Flurochromes commonly used in mammals include tetracycline, calcein green, xylenol 
orange, alirazin red, and hematoporphyrin. Calcein is a fluoresces bright green when 
combined with calcium (Stuart and Smith, 1992).  
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6.2.2 Calcein administrations and sections preparation  
The steps needed for detecting the double labeling involves the following:  
 Rats are subcutaneously injected with 50 mg/kg body weight calcein fluorescent 
marker on day 21 and day 28 after STZ injection.  The time difference between the 2 
injections is one week to be able to compare the amount of bone formed during this 
period (Fig. 14).  
 Sacrifice of all animals by transcardiac perfusion under deep anesthesia using 4% 
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). 
  Mandibles are dissected and fixed in the same solution for 24 hours.   
 All specimens are embedded in polystyrene resin (Rigolac, Nisshin EM Co. Ltd., Tokyo, 
Japan). 
 Undemineralized ground frontal sections are processed to show the crown and both 
apices of buccal and lingual roots of the lower second molar (Shimomoto et al., 2007).   
 
Region 1: Alveolar Crest
Region 2: Alveolar Bone
Region 3: Buccal surface
Reference Line
Region 4: Inferior Border  
Fig. 13. Schematic drawing of observation regions for dynamic bone histomorphometry. The 
periosteal surfaces were delimited into 4 areas as alveolar crest (region 1), alveolar bone 
(region 2), buccal surface of the jaw bone (region 3), and inferior border of the jaw bone 
(region 4). 
6.2.3 Method of analysis 
The bone around the lower second molar is centrally located within the mandibular arch, and 
because of the parallel alignment of the buccal and lingual roots this made a precise reference 
when frontal sections are produced (Shimomoto et al., 2005). To conduct the 
histomorphometric analysis it is essential to use a digitizing morphometry system to measure 
bone formation indices.  The system consists of a confocal laser scanning microscope (LSM510, 
Carl Zeiss Co. Ltd., Jena, Germany), and a morphometry program (LSM Image Browser, Carl 
Zeiss Co. Ltd., Jena, Germany).  Bone formation indices of the periosteal surfaces of the 
alveolar/jaw bone include mineral apposition rate (μm/day) and bone formation rate 
(μm3/μm2/day), according to the standard nomenclature described by (Parfitt et al., 1987).  
The calcein-labeled surface (CLS, in mm) is calculated as the sum of the length of double labels 
(dL) plus one half of the length of single labels (sL) along the entire endosteal or periosteal 
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bone surfaces; that is, CLS ═ dL + 0.5sL (Keshawarz and Recker, 1986).  The mineral 
apposition rate (MAR, in μ/day) is determined by dividing the mean of the width of the 
double labels by the interlabel time (7 days).  The bone formation rate (BFR) is calculated by 
multiplying MAR by CLS (Sheng et al., 1999).  Based on the reference line along the long axis of 
the buccal root, the area superior to the root apex was considered alveolar bone, while the area 
inferior to the root apex was considered the jaw bone.  The lingual side of the bone is excluded, 
because the existence of the incisor root may influence bone formation.   
The periosteal surfaces of the mandible are divided into four regions for analysis (Fig. 13):  
Region 1: alveolar crest (upper 1/2 of the tooth root, near the tooth crown) 
Region 2: alveolar bone (lower 1/2 of the tooth root, near the root apex) 
Region 3: buccal surface of the jaw bone 
Region 4: inferior border of the jaw bone 
6.2.4 Histomorphometric indices 
The obtained results in our study showed that in the alveolar bone (region 2), there was a 
significant decrease in the MAR (Fig. 15A) BFR (Fig. 15B) recorded in the DM group compared 
to the control group.  However, in the alveolar crest (region 1), the MAR and the BFR in the 
control and the DM groups were not significantly different. (p<0.05). In the buccal surface 
(region 3) and inferior borders (region 4) of the jaw bone the MAR (Fig. 15A) and BFR (Fig. 15B) 
were significantly suppressed compared with those in the control group (p<0.05). Most of the 
periosteal surfaces in the mandibular regions of the control group showed significantly higher 
values recorded for the mineral apposition rate and the bone formation rate when compared to 
the DM group.  These results agree with previous studies that recorded diminished lamellar 
bone formation in DM rats’ femur and may suggest an association between the DM condition 
and the decreased number and function of osteoblasts (Follak et al., 2004; Shyng et al., 2001).  
The alveolar crest region was the only region that did not show a significant difference in the 
mineral apposition rate and the bone formation rate parameters among the two groups;  this 
may be attributed to the unique nature of this region exhibiting a highly intensive bone 
remodeling process especially during the teeth eruption that decreases toward the base of the 
socket (Gerlach et al., 2002), however further studies are needed to elaborate the detailed pattern 
of bone growth at the alveolar crest region.  
 
DM
 
Fig. 14. Frontal sections of the mandibular second molar area.  (A) Control; (B) DM. 
Fluorescent labeling on the periosteal surface indicates new bone formation. 
Control 
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Fig. 15. (A) The changes in mineral apposition rate (MAR) of the mandible between the 
control group and the DM group.  Alveolar crest (region 1, upper 1/2 of the tooth root, near 
the tooth crown).  Alveolar bone (region 2, lower 1/2 of the tooth root, near the root apex).  
Buccal surface of the jaw bone (region 3). Inferior border of the jaw bone (region 4). The data 
are expressed as means ± SD. n = 5 for each group. *:p<0.05. (B) The changes in the bone 
formation rate (BFR/BS) of the mandible between the control group and the DM group. 
Alveolar crest (region 1, upper 1/2 of the tooth root, near the tooth crown). Alveolar bone 
(region 2, lower 1/2 of the tooth root, near the root apex). Buccal surface of the jaw bone 
(region 3). Inferior border of the jaw bone (region 4). The data are expressed as means ± S.D. 
n = 5 for each group. *:p<0.05. 
6.3 Microtomography of the mandible (micro-CT) 
Micro-computed tomography (micro-CT) has rapidly become a standard technique for the 
visualization and quantification of the 3D structure of trabecular bone. Bone architecture 
and mineralization are generally considered to be important components of bone quality, 
and determine bone strength in conjunction with bone mineral density.  
6.3.1 Protocol adopted to examine the mandible using micro-CT 
In our study all specimens were imaged by micro-CT (inspeXio SMX-90CT; Shimadzu 
Science East Corporation, Tokyo, Japan)  
 After removing only the soft tissue, the mandibular plane is set orthogonal to the 
sample stage. 
 Three dimensional images of each hemi mandible are acquired with a resolution voxel 
size of 15 μm / pixel.  
 Raw data are obtained by rotating the sample stage 360 degrees.  Then, slice images are 
prepared using multi-tomographic image reconstruction software (MultiBP; 
Imagescript, Tokyo, Japan).   
 The resulting gray-scale images are segmented using a low-pass filter to remove noise 
and a fixed threshold to extract the mineralized bone phase.   
 The volume of interest is drawn on a slice-based method starting from the first slice 
containing the crown of the first molar and moving dorsally 100 slices (Laib and 
Ruegsegger, 1999; Zhang et al., 2008), in the area of the alveolar crest (Between the buccal 
and lingual roots of the second molar at the cervical region); and the buccal surface of the 
jaw bone (Shimomoto et al., 2007).  Trabecular bone was carefully contoured on the first 
and the last slice, while the intermediate slices were first interpolated by morphing.  
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 For observation and analysis of reconstructed 3D images, 3D trabecular structure 
analysis software (TRI/3D-BON; RATOC System Engineering, Tokyo, Japan) is used 
(Takada et al., 2006).  Reconstructed 3D images were prepared from slice images using 
the volume rendering method, to analyze the microstructure of the bone (Fig. 16).  
 The following parameters are measured: tissue volume (TV), bone volume (BV), bone 
surface (BS), bone surface / bone volume (BS/BV), bone-volume fraction (BV/TV).   
 Four properties of the trabeculae are evaluated: trabecular thickness (Tb.Th), trabecular 
number (Tb.N), trabecular separation (Tb.Sp), and Trabecular space (Tb.S) (Nakano et 
al., 2004; Takada et al., 2006). 
 
 
Fig. 16. The left mandible was imaged by micro-CT 
6.3.2 Microtomography of the DM mandible 
The quantification of micro-CT trabecular bone changes (mean±SD) is shown for the DM 
and the control groups in (Table 4).  All trabecular parameters in both alveolar bone and 
buccal surface of jaw bone showed significant changes.  Compared with the control group, 
bone volume fraction (BV/TV) was significantly decreased only in the alveolar bone; 
however, trabecular thickness (Tb.Th) and trabecular numbers (Tb.N) were significantly 
decreased both in alveolar and buccal surface of jaw bone, in the DM group. 
Correspondingly, significantly higher trabecular separation (Tb.Sp) and trabecular space 
(Tb.S) were revealed both in alveolar and buccal surface of jaw bone for the DM group when 
compared with that of the control group.  Also, the bone surface / bone volume (BS/BV) 
was significantly increased only in alveolar bone (p<0.05). These findings indicate 
deterioration of the bone quality in the DM group.  These results agree with other research 
work suggesting that the glycaemic levels play an important role in modulating the 
trabecular architecture especially in mandibular bone (Thrailkill et al., 2005). 
The DM condition resulted in alteration of the trabecular distance and thickness as 
compared to the control group indicating profound impact on the histological integrity of 
the bone.  The reduction in trabecular bone volume accompanied by the expansion of the 
bone marrow space is in agreement with another investigation (Duarte et al., 2005).  In this 
context, these results may describe a state of osteopenia in experimental diabetic rats, which 
might be the result of an imbalance between bone formation and resorption 
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Table 8. Microarchitectural properties in the mandible as measured by micro-CT 
6.4 Histological analysis 
6.4.1 Procedure for preparing mandibles for histological analysis 
 Mandibles for all groups were decalcified in 10% EDTA solution pH 7.4 for 5 weeks at 
4ºC (Yokoyama et al., 2009).   
 Specimens are then dehydrated in an ascending ethanol series and embedded in 
paraffin (Figs. 9, 10, 11).   
 Serial horizontal sections (5 μm thick parallel to the occlusal plane) are prepared using a 
microtome (Leica RM 2155, Nussloch, Germany) (Figs. 12, 13) 
 
 
 
 
Fig. 17. Experimental procedure for histological section preparation 
Serial horizontal sections were prepared using a microtome
(5 µm thick parallel to the occlusal plane) 
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6.4.2 TRAP staining 
Histological sections are incubated for 30–60 min at 37ºC in a mixture of 0.8% naphthol AS-BI 
phosphate (Sigma, St Louis, MO, USA), 0.7% fast red violet salt (Sigma, St Louis, MO, USA) 
and 50mM sodium tartate diluted in 0.2M sodium acetate buffer (pH 5.4) (Tsuchiya and 
Kurihara, 1995).  Sections were examined under a light microscope.  For the 
histomorphometric assessment of resorption, the number of tartrate-resistant acid 
phosphatase-positive multinucleated cells (osteoclasts) on the distal surface of the alveolar 
bone adjacent to the mesio-buccal root of the second molar were counted in each 540 μm x 120 
μm area in five consecutive sections, at the middle third of the root selected at least 25μm apart 
from each specimen (n = 5) of each group (Misawa et al., 2007; Mishima et al., 2002).         
6.4.3 Histological analysis 
Bone-resorption activity was assessed by counting the number of tartrate-resistant acid 
phosphatase-positive multinucleate cells (osteoclasts) on the distal surface of the alveolar 
bone adjacent to the mesio-buccal root of the second molar (Fig. 18A-D).  Statistical analysis  
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Fig. 18. Osteoclast counts in a horizontal section of the mandibular second molar region stained 
with Tartarate-resistant acid phosphatase (TRAP). (A) Low magnification photograph of the 
three roots of the second molar stained with TRAP stain. The black rectangle (540 X 120 μm) 
indicates the area on the distal surface of the alveolar bone adjacent to the middle third of the 
mesio-buccal root of the second molar in which the osteoclast cells were counted. Bu, buccal; Li, 
lingual; Me, mesial; Di, distal. (B) The mesio-buccal root of the control rat (original magnification 
100X). (C) The mesio-buccal root of the DM rat (original magnification 100X). (D) A schematic 
drawing showing the observation area on the distal surface of the alveolar bone adjacent to the 
mesio-buccal root of the second molar in which the osteoclast cells were counted. (E) The number 
of TRAP-positive cells on the distal surface of the mesio-buccal root of the mandibular second 
molar. Values are mean ± SD. *:(p<0.05), bars = 100 µm. 
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demonstrated a significantly higher number of osteoclast cells in the control group when 
compared with the DM group (p<0.05) (Fig. 18). Results revealed that the number of 
osteoclasts was significantly lower in the DM rats than in the controls, in line with previous 
studies on DM rats’ mandible (Mishima et al., 2002) and long bones (Glajchen et al., 1988; 
Shires et al., 1981).  These results confirm that the decreased rate of bone turnover may be 
associated with the DM condition. 
7. Suggested mechanisms for the effect of diabetic condition on craniofacial 
complex 
Growth of the craniofacial complex is controlled by genetic and environmental factors 
(Giglio and Lama, 2001; Yonemitsu et al., 2007).  Regulatory mechanisms responsible for 
normal morphogenesis of the face and head involve hormones, nutrients, mechanical forces, 
and various local growth factors.  The poor growth and alterations in bone metabolism have 
been associated with T1DM in both humans and experimental animals (Giglio and Lama, 
2001). Because human studies can be limited by small sample sizes, cross-sectional designs, 
uncontrolled variables, and often retrospective nature, animal models have been used to 
yield more rigorous analyses (Singleton et al., 2006).  In our studies we observed the rat 
growth from the age of 3 weeks old till 7 weeks old.  This time period is corresponding to 
early growth stage in human according to previous craniofacial growth studies (Losken et 
al., 1994; Siegel and Mooney, 1990).  Consequently, in the current study STZ-DM model was 
used to investigate the effect of T1DM on craniofacial growth. 
The studied STZ-DM rats showed significantly reduced growth in most of the craniofacial 
skeletal units but no significant differences were observed between controls and DM group 
as regards the remaining craniofacial skeletal units (Sphenoid bone length, posterior 
neurocranium height, anterior corpus length, bigonial width and palatal width).  
Craniofacial growth as a whole was also significantly lower in DM group compared to 
controls in all three dimensions.  Previous study investigated the DM effect exclusively on 
the growth of the mandible and suggested that the diabetic condition had a differential 
effect on the osseous components and / or its associated non-skeletal tissues. They found 
that the disharmonious growth of the mandible was due to DM condition and might not be 
associated with diabetic condition complications such as renal failure, anemia, body weight 
change or alteration in the food intake qualities (Giglio and Lama, 2001).  Thus we 
hypothesize that the deficiency in the craniofacial growth in our experiment might be 
attributed to the diabetic condition in the DM group as it was reported that specific 
alterations in bone metabolism are associated with DM.  Moreover, several pathogenic 
possibilities have been proposed, such as insulinopenia, bone microangiopathy, impaired 
regulation of mineral metabolism, alterations in local factors that regulate bone remodeling, 
and even an intrinsic disorder associated with T1DM (Duarte et al., 2005; Ward et al., 2001).  
The aforementioned insulin hormone deficiency that is associated with T1DM cases may 
have direct effect on bone metabolism.  It was mentioned in literature that normal insulin 
hormone level exerts direct anabolic effects on bone cells (Duarte et al., 2005).  Multiple 
osteoblast-like cell lines express insulin receptors on the cell surface and have a high 
capacity for insulin binding (Pun et al., 1989).  Moreover, osteoclasts exhibit reduced bone 
resorption in response to insulin stimulation (Thomas et al., 1998).  These findings support 
the idea that the actions of insulin in bone could be mediated directly via stimulation of 
osteoblasts in combination with inhibition of osteoclasts, (Thomas et al., 1998; Thrailkill et al., 
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2005) and this mechanism of action may explain the retardation of craniofacial growth in 
STZ-DM. 
Diabetes has a deleterious effect on osseous turnover due to decreased osteoblast and 
osteoclast activities and numbers and, a lower percentage of osteoid surface and osteocalcin 
synthesis, as well as increased time for mineralization of osteoid (Duarte et al., 2005).  It was 
reported that the influence of diabetes on discrete stages of matrix-induced endochondral 
bone formation could have profound effects on the biomechanical behavior of bone.  Also, 
chondrogenesis and calcification of bone were reduced by 50% in diabetic animals (Reddy et 
al., 2001).   This was evident in the current study results that showed a significant decrease in 
the craniofacial linear measurements of the DM group. 
In addition to this, insulin may exert synergistic effects with other anabolic agents in bone, 
such as parathyroid hormone (PTH) (Thomas et al., 1998; Thrailkill et al., 2005).  An animal 
model of T1DM has frequently demonstrated alteration in bone turnover, retarded growth, 
increased concentration of PTH, and reduced concentration of 1,25-dihydroxivitamin D 
(Duarte et al., 2005; Tsuchida et al., 2000). The effects of PTH on the bones are complex; it 
stimulates resorption or bone formation depending on the concentration used, the duration 
of the exhibition, and the administration method (Duarte et al., 2005; Toromanoff et al., 1997; 
Tsuchida et al., 2000).  Also, 1,25-dihydroxivitamin D, like PTH, belongs to the most 
important group of bone regulatory hormones.  It regulates osteoclastic differentiation from 
hematopoietic mononuclear cells, and osteoblastic functions and activity (Collins et al., 1998; 
Duarte et al., 2005). 
Moreover, Insulin may indirectly regulate the enhancement of growth hormone serum 
concentration by direct regulation of the hepatic growth hormone receptor, this results in 
abnormalities in the insulin growth factor-1 in T1DM (Chiarelli et al., 2004) which 
consequently may have lead to the retarded growth in uncontrolled DM in the current 
study. 
In the present study most of the periosteal surfaces in the mandibular regions of the 
control group showed significantly higher values recorded for the mineral apposition rate 
and the bone formation rate when compared to the DM group.  These results agree with 
previous studies that recorded diminished lamellar bone formation in DM rats’ femur and 
may suggest an association between the DM condition and the decreased number and 
function of osteoblasts (Follak et al., 2004; Shyng et al., 2001).  The alveolar crest region 
was the only region that did not show a significant difference in the mineral apposition 
rate and the bone formation rate parameters among the two groups;  this may be 
attributed to the unique nature of this region exhibiting a highly intensive bone 
remodeling process especially during the teeth eruption that decreases toward the base of 
the socket  (Gerlach et al., 2002). 
Micro CT analysis showed a significant decrease of bone volume fraction, trabecular 
thickness, and trabecular number. Also, it showed a significant increase of the trabecular 
separation and the trabecular space in the DM group when compared with the control 
group. This finding indicates deterioration of the bone quality in the DM group.  These 
results agree with other research work suggesting that the glycaemic levels play an 
important role in modulating the trabecular architecture especially in mandibular bone 
(Thrailkill et al., 2005). In this context, these results may describe a state of osteopenia in 
experimental diabetic rats, which might be the result of an imbalance between bone 
formation and resorption. 
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A histometric evaluation of bone resorption was performed by counting the number of 
osteoclast cells on the distal surface of the alveolar bone adjacent to the mesio-buccal root of 
the second molar.  These evaluations revealed that the number of osteoclasts was 
significantly lower in the DM rats than in the controls, in line with previous studies on DM 
rats’ mandible (Mishima et al., 2002) and long bones (Glajchen et al., 1988; Shires et al., 1981).  
These studies confirm that the decreased rate of bone turnover may be associated with the 
DM condition. 
This deteriorating effect on mandibular bone structure and dynamic bone formation might 
be be attributed to several pathogenic possibilities, such as insulinopenia, bone 
microangiopathy, impaired regulation of mineral metabolism, alterations in local factors 
that regulate bone remodeling, and even an intrinsic disorder associated with DM (Abbassy 
et al., 2008; Duarte et al., 2005).  However, the detrimental effects observed may not be 
associated with the significant loss of rats` weights observed in the diabetic group starting 
from day 14 because previous research (Abbassy et al., 2008; Giglio and Lama, 2001; Shires et 
al., 1981; Thrailkill et al., 2005) showed that the mandibular growth was not affected in 
normal rats supplied with restricted diet and having same pattern of weight loss resembling 
weight loss pattern observed in DM rats.      
8. Conclusions 
It is obvious that the T1DM condition significantly affects craniofacial growth, bone 
formation mechanism and the quality of the bone formed which may alter many aspects of 
planning and treatment of orthodontic patients affected by this globally increasing 
hormonal disturbance. 
There should be a new strategy for treating orthodontic patients suffering from metabolic 
disorders specially those disorders having direct and indirect effects on bone growth as the 
diabetic condition.  The orthodontic craniofacial linear measurements were significantly 
decreased in the T1DM cases when compared to normal cases.  These facts should be 
considered when orthodontic problems are diagnosed and treated in T1DM, because this 
may alter the orthodontic treatment period and the final treatment outcome.  In this chapter 
it was suggested that a better understanding of how diabetes affects bone will improve our 
ability to protect bone health in diabetic patients.  Also, it was recommended to conduct 
further studies in order to elucidate the exact mechanism by which diabetes produces 
alterations in most of the craniofacial units.   
Thus, T1DM condition had detrimental effects on the different bone regions of the mandible, 
that shed the light on the complexity of the craniofacial structure which is affected by many 
hormonal disorders suggesting further examination for the overlying soft tissues which are 
directly affected by any underlying boney changes.  Diabetes condition had detrimental 
effect on bone architecture, as shown by micro-CT, and impaired the rate of the mandibular 
bone formation, as examined by the dynamic histomorphometric analysis.  All of these 
results were verified on the cellular level by a histological study that showed the diminished 
number of osteoclasts on the alveolar wall, suggesting that the early stage of T1DM resulted 
in low bone turnover.  These results may suggest that more care is needed during the 
consideration of the force needed for treatment of orthodontic patients affected by T1DM, 
also, the retention period and rate of success in these patients may be affected.    
These comprehensive studies done on bone and craniofacial growth suggest that planning 
the treatment in craniofacial region  for patients affected with hormonal disorders is a more 
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complex procedure when compared to the treatment of normal patients, moreover it is 
suggested that it is of prime importance to keep close attention to the general systemic 
condition of these patients and administer the proper hormonal therapy for these patients 
when needed to avoid any detrimental effects on bone resulting from any hormonal 
imbalance.  
Within the limitations of this in vitro study, it was concluded that: 
1. T1DM reduces craniofacial growth, resulting in retardation of skeletal development. 
2. DM in the rat affects the bone architecture, as shown by micro-CT, and impairs the rate 
of the mandibular bone formation, as examined by the dynamic histomorphometric 
analysis. 
3. All of these results were verified on the cellular level by a histological study that 
showed the diminished number of osteoclasts on the alveolar wall, suggesting that the 
early stage of DM resulted in low bone turnover.  
4. These findings should be considered when conducting any treatment in the craniofacial 
region in T1DM since the better understanding of how diabetes affects bone will 
improve our ability to protect bone health in diabetic patients.  
5. Good control of diabetes mellitus should be considered before orthodontic treatment by 
a long time inorder to obtain the best outcome. 
9. References 
Abbassy MA, Watari I, Soma K (2008). Effect of experimental diabetes on craniofacial 
growth in rats. Archives of Oral Biology, Vol.53, No.9, (September 2008), pp. 819-825 
Abbassy MA, Watari I, Soma K (2010). The effect of diabetes mellitus on rat mandibular 
bone formation and microarchitecture European Journal of Oral Sciences, Vol.118, 
No.4, (August 2010), pp. 364-369 
Abdus Salam M, Matsumoto N, Matin K, Tsuha Y, Nakao R, Hanada N, Senpuku H (2004). 
Establishment of an animal model using recombinant NOD.B10.D2 mice to study 
initial adhesion of oral streptococci. Clinical and Diagnostic Laboratory Immunology, 
Vol.11, No.2, (March 2004), pp. 379-386 
Alkan A, Erdem E, Gunhan O, Karasu C (2002). Histomorphometric evaluation of the effect 
of doxycycline on the healing of bone defects in experimental diabetes mellitus: a 
pilot study. Journal of Oral and Maxillofacial Surgery, Vol. 60, No.8, (August 2002), 
pp.898-904 
Bensch L, Braem M, Van Acker K, Willems G (2003). Orthodontic treatment considerations 
in patients with diabetes mellitus. American Journal of Orthodontics and Dentofacial 
Orthopedics, Vol.123, No.1, (January 2003), pp. 74-78 
Chew FS (1991). Radiologic manifestations in the musculoskeletal system of miscellaneous 
endocrine disorders. Radiologic Clinics of North America, Vol.29, No.1,  
(January1991), pp. 135-147, ISSN 0033-8389 
Chiarelli F, Giannini C, Mohn A (2004). Growth, growth factors and diabetes. European 
Journal of Endocrinology, Vol.151, Suppl 3, (November 2004), pp.U109-117 
Chidiac JJ, Shofer FS, Al-Kutoub A, Laster LL, Ghafari J (2002). Comparison of CT 
scanograms and cephalometric radiographs in craniofacial imaging. Orthodontics 
and Craniofacial Research, Vol.5, No.2, (May 2002), pp.104-113 
Collins D, Jasani C, Fogelman I, Swaminathan R (1998). Vitamin D and bone mineral 
density. Osteoporosis International, Vol.8, No.2, (March 1998), pp. 110-114, ISSN 
0937-941X 
www.intechopen.com
 Type 1 Diabetes Complications 
 
460 
Duarte VM, Ramos AM, Rezende LA, Macedo UB, Brandao-Neto J, Almeida MG, Rezende 
AA (2005). Osteopenia: a bone disorder associated with diabetes mellitus. Journal of 
Bone and Mineral Metabolism, Vol.23, No.1, (January 2005), pp. 58-68 
Eastell R, Lambert H (2002). Diet and healthy bones. Calcified Tissue International, Vol.70, 
No.5, (May 2002), pp. 400-404 
Engstrom C, Jennings J, Lundy M, Baylink DJ (1988). Effect of bone matrix-derived growth 
factors on skull and tibia in the growing rat.  Journal of Oral Pathology, Vol.17, No.7, 
(August 1988), pp. 334-340, ISSN 0300-9777 
Follak N, Kloting I, Wolf E, Merk H (2004). Histomorphometric evaluation of the influence 
of the diabetic metabolic state on bone defect healing depending on the defect size 
in spontaneously diabetic BB/OK rats. Bone, Vol.35, No.1, (July 2004), pp. 144-152 
Gerlach RF, Toledo DB, Fonseca RB, Novaes PD, Line SR, Merzel J (2002). Alveolar bone 
remodelling pattern of the rat incisor under different functional conditions as 
shown by minocycline administration. Archives of  Oral Biology, Vol.47, No.3, 
(March 2002), pp. 203-209 
Giglio MJ, Lama MA (2001). Effect of experimental diabetes on mandible growth in rats. 
European Journal of Oral Sciences, Vol.109, No.3, (June 2001), pp. 193-197 
Glajchen N, Epstein S, Ismail F, Thomas S, Fallon M, Chakrabarti S (1988). Bone mineral 
metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone 
remodeling. Endocrinology, Vol.123, No.1, (July 1988), pp. 290-295, ISSN 0013-7227 
Hough S, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL (1981). 
Correction of abnormal bone and mineral metabolism in chronic streptozotocin-
induced diabetes mellitus in the rat by insulin therapy. Endocrinology, Vol. 108, 
No.6, (June 1981), pp. 2228-2234, ISSN 0013-7227 
Keshawarz NM, Recker RR (1986). The label escape error: comparison of measured and 
theoretical fraction of total bone-trabecular surface covered by single label in normals 
and patients with osteoporosis. Bone, Vol. 7, No.2, (February 1986), pp. 83-87 
Kiliaridis S EC, Thilander B. (1985). The relationship between masticatory function and 
craniofacial morphology. I. A cephalometric longitudinal analysis in the growing 
rat fed a soft diet. European Journal of Orthodontics, Vol.7, pp. 273-283 
Kitabchi AE UG, Murphy MB, Barrett EJ, Kreisberg, RA, Malone JI, et al. (2001). 
Management of hyper-glycemic crises in patients with diabetes. Diabetes Care, 
Vol.24, pp. 131-153 
Kumar P, Clark, M. (2009). Kumar and Clark's Clinical Medicine (7th edition), Elsevier, ISBN 
10: 0-7020-2993-9, ISBN 13: 978-0-7020-2993-6, London, UK 
Laib A, Ruegsegger P (1999). Calibration of trabecular bone structure measurements of in vivo 
three-dimensional peripheral quantitative computed tomography with 28-microm-
resolution microcomputed tomography. Bone, Vol.24, No.1, (January 1999), pp. 35-39 
Losken A, Mooney MP, Siegel MI (1994). Comparative cephalometric study of nasal cavity 
growth patterns in seven animal models. Cleft Palate Craniofacial Journal, Vol.31, 
No.1, (January 1994), pp.17-23 
Lu H, Kraut D, Gerstenfeld LC, Graves DT (2003). Diabetes interferes with the bone 
formation by affecting the expression of transcription factors that regulate 
osteoblast differentiation. Endocrinology, Vol.144, No.1, (January 2003), pp.346-352, 
ISSN 0013-7227 
Matin K, Salam MA, Akhter J, Hanada N, Senpuku H (2002). Role of stromal-cell derived 
factor-1 in the development of autoimmune diseases in non-obese diabetic mice. 
Immunology, Vol.107, No.2, (October 2002), pp.222-232, ISSN 0019-2805 
www.intechopen.com
 The Effect of Type 1 Diabetes Mellitus on the Craniofacial Complex 
 
461 
McCracken MS, Aponte-Wesson R, Chavali R, Lemons JE (2006). Bone associated with 
implants in diabetic and insulin-treated rats. Clinical Oral Implants Research, Vol.17, 
No.5, (October 2006), pp. 495-500 
Misawa Y, Kageyama T, Moriyama K, Kurihara S, Yagasaki H, Deguchi T, Ozawa H, Sahara 
N (2007). Effect of age on alveolar bone turnover adjacent to maxillary molar roots 
in male rats: A histomorphometric study. Archives of Oral Biology, Vol.52, No.1, 
(January 2007), pp. 44-50 
Mishima N, Sahara N, Shirakawa M, Ozawa H (2002). Effect of streptozotocin-induced 
diabetes mellitus on alveolar bone deposition in the rat. Archives of Oral Biology, 
Vol.47, No.12, (December 2002), pp. 843-849, ISSN 0003-9969 
Nakano H, Maki K, Shibasaki Y, Miller AJ (2004). Three-dimensional changes in the condyle 
during development of an asymmetrical mandible in a rat: a microcomputed 
tomography study. American Journal of Orthodontics and Dentofacial Orthopedics, 
Vol.126, No.4, (October 2004), pp. 410-420 
Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker 
RR (1987). Bone histomorphometry: standardization of nomenclature, symbols, and 
units. Report of the ASBMR Histomorphometry Nomenclature Committee. Journal 
of Bone and Mineral Research, Vol.2, No.6, (December 1987), pp. 595-610 
Pun KK, Lau P, Ho PW (1989). The characterization, regulation, and function of insulin 
receptors on osteoblast-like clonal osteosarcoma cell line. Journal of Bone and Mineral 
Research, Vol.4, No.6, (December 1989), pp. 853-862 
Reddy GK, Stehno-Bittel L, Hamade S, Enwemeka CS (2001). The biomechanical integrity of 
bone in experimental diabetes. Diabetes Research and Clinical Practice, Vol.54, No.1, 
pp. 1-8, ISSN 0168-8227 
Salzmann JA (1966). Practice of orthodontics. American Journal of Orthodontics, Vol. 76, No.1, 
(July 1979), pp. 103-104 
Schwartz AV (2003). Diabetes Mellitus: Does it Affect Bone? Calcified Tissue International, 
Vol.73, No.6, (December 2003), pp. 515-519 
Sheng MH, Baylink DJ, Beamer WG, Donahue LR, Rosen CJ, Lau KH, Wergedal JE (1999). 
Histomorphometric studies show that bone formation and bone mineral apposition 
rates are greater in C3H/HeJ (high-density) than C57BL/6J (low-density) mice 
during growth. Bone, Vol.25, No.4, (October 1999), pp. 421-429 
Shimomoto Y, Chung CJ, Iwasaki-Hayashi Y, Muramoto T, Soma K (2007). Effects of 
occlusal stimuli on alveolar/jaw bone formation. Journal of Dental Research, Vol.86, 
No.1, (January 2007), pp. 47-51 
Shimomoto Y IY, Chung C-R, Muramoto T, Soma K. ( 2005). Occlusal stimuli affects alveolar 
and jaw bone formation during the growth period. . Journal of Japanese Society of 
Bone Morphometry, Vol.15, No.1, pp. 29–34, ISSN 0917-4648 
Shires R, Teitelbaum SL, Bergfeld MA, Fallon MD, Slatopolsky E, Avioli LV (1981). The 
effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral 
homeostasis in the rat. Journal of Laboratory Clinical Medicine, Vol.97, No.2, (February 
1981), pp. 231-240, ISSN 0022-2143 
Shyng YC, Devlin H, Sloan P (2001). The effect of streptozotocin-induced experimental 
diabetes mellitus on calvarial defect healing and bone turnover in the rat. International 
Journal of Oral and Maxillofacial Surgery, Vol.30, No.1, (February 2001), pp. 70-74 
Siegel MI, Mooney MP (1990). Appropriate animal models for craniofacial biology. Cleft 
Palate Journal, Vol.27, No.1, (January 1990), pp. 18-25 
www.intechopen.com
 Type 1 Diabetes Complications 
 
462 
Singleton DA, Buschang PH, Behrents RG, Hinton RJ (2006). Craniofacial growth in growth 
hormone-deficient rats after growth hormone supplementation. American Journal of 
Orthodontics and Dentofacial Orthopedics, Vol.130, No.1, (July 2006), pp. 69-82 
Stuart A, Smith D (1992). Use of the Fluorochromes xylenol orange, calcein green, and 
tetracycline to document bone deposition and remodeling in healing fractures in 
chickens. Avian diseases, Vol.36, (July 1992), pp. 447-449 
Takada H, Abe S, Tamatsu Y, Mitarashi S, Saka H, Ide Y (2006). Three-dimensional bone 
microstructures of the mandibular angle using micro-CT and finite element 
analysis: relationship between partially impacted mandibular third molars and 
angle fractures. Dent Traumatol, Vol.22, No.1, (February 2006), pp. 18-24 
Tein MS, Breen SA, Loveday BE, Devlin H, Balment RJ, Boyd RD, Sibley CP, Garland HO 
(1998). Bone mineral density and composition in rat pregnancy: effects of 
streptozotocin-induced diabetes mellitus and insulin replacement. Experimental 
Physiology, Vol.83, No.2, (March 1998), pp. 165-174 
Thomas DM, Udagawa N, Hards DK, Quinn JM, Moseley JM, Findlay DM, Best JD (1998). 
Insulin receptor expression in primary and cultured osteoclast-like cells. Bone, 
Vol.23, No.3, (September 1998), pp. 181-186 
Thrailkill KM, Liu L, Wahl EC, Bunn RC, Perrien DS, Cockrell GE, Skinner RA, Hogue WR, 
Carver AA, Fowlkes JL, Aronson J, Lumpkin CK, Jr. (2005). Bone formation is impaired 
in a model of type 1 diabetes. Diabetes, Vol.54, No.10, (October 2005), pp. 2875-2881 
Toromanoff A, Ammann P, Mosekilde L, Thomsen JS, Riond JL (1997). Parathyroid hormone 
increases bone formation and improves mineral balance in vitamin D-deficient 
female rats. Endocrinology, Vol.138, No.6, (June 1997), pp. 2449-2457, ISSN 0013-7227 
Tsuchida T, Sato K, Miyakoshi N, Abe T, Kudo T, Tamura Y, Kasukawa Y, Suzuki K (2000). 
Histomorphometric evaluation of the recovering effect of human parathyroid 
hormone (1-34) on bone structure and turnover in streptozotocin-induced diabetic 
rats. Calcified Tissue International, Vol.66, No.3, (March 2000), pp. 229-233 
Tsuchiya T MY, Kurihara S. (1995). The fluorescent simultaneous azo dye technique for 
demonstration of tartarate -resistant acid phosphatase (TRAP) activity in osteoclast-
like multinucleate cells. Journal of Bone and Mineral Metabolism, Vol.13, pp. 71-76 
Vandeberg JR, Buschang PH, Hinton RJ (2004a). Craniofacial growth in growth hormone-
deficient rats. The Anatomical Record. Part A, Discoveries in Molecular, Cellular and 
Evolutionary Biology, Vol.278, No.2, (June 2004), pp. 561-570, ISSN 1552-4884 
VandeBerg JR, Buschang PH, Hinton RJ (2004b). Absolute and relative growth of the rat 
craniofacial skeleton. Archives of  Oral Biology, Vol.49, No.6, (June 2004), pp. 477-484, 
ISSN 0003-9969Ward DT, Yau SK, Mee AP, Mawer EB, Miller CA, Garland HO, 
Riccardi D (2001). Functional, molecular, and biochemical characterization of 
streptozotocin-induced diabetes. Journal of the American Society of Nephrology, Vol.12, 
No.4, pp. 779-790, ISSN 1046-6673 
Yokoyama M, Atsumi T, Tsuchiya M, Koyama S, Sasaki K (2009). Dynamic changes in bone 
metabolism in the rat temporomandibular joint after molar extraction using bone 
scintigraphy. Europen Journal of Oral Sciences, Vol.117, No. 4, (August 2009), pp. 374-
379, ISSN 1600-0722 
Yonemitsu I, Muramoto T, Soma K (2007). The influence of masseter activity on rat 
mandibular growth. Archives of  Oral Biology, Vol.52, No.5, (May 2007), pp. 487-493, 
ISSN 0003-9969 
Zhang X, Fei Y, Zhang M, Wei D, Li M, Ding W, Yang J (2008). Reversal of osteoporotic 
changes of mineral composition in femurs of diabetic rats by insulin. Biological Trace 
Element Research, Vol.121, No.3, (March 2008), pp. 233-242  
www.intechopen.com
Type 1 Diabetes Complications
Edited by Prof. David Wagner
ISBN 978-953-307-788-8
Hard cover, 482 pages
Publisher InTech
Published online 25, November, 2011
Published in print edition November, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
This book is a compilation of reviews about the complication of Type 1 Diabetes. T1D is a classic autoimmune
disease. Genetic factors are clearly determinant but cannot explain the rapid, even overwhelming expanse of
this disease. Understanding etiology and pathogenesis of this disease is essential. The complications
associated with T1D cover a range of clinical obstacles. A number of experts in the field have covered a range
of topics for consideration that are applicable to researcher and clinician alike. This book provides apt
descriptions of cutting edge technologies and applications in the ever going search for treatments and cure for
diabetes.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Mona Abbassy, Ippei Watari and Takashi Ono (2011). The Effect of Type 1 Diabetes Mellitus on the
Craniofacial Complex, Type 1 Diabetes Complications, Prof. David Wagner (Ed.), ISBN: 978-953-307-788-8,
InTech, Available from: http://www.intechopen.com/books/type-1-diabetes-complications/the-effect-of-type-1-
diabetes-mellitus-on-the-craniofacial-complex
© 2011 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
